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    Department of Biomechanical Engineering 
Rayne Institute, Lambeth Wing, 3rd floor 
King’s College London, London SE1 7EH 
 
24th July 2018 
 
Dear Professor William Roberts, 
 
 
What proportion of patients with Heart Failure and LVEF 40-49% fulfil the 
criteria for Heart Failure with mid range Ejection Fraction? 
 
Thank you for taking the time to review our research letter to the American 
Journal of Cardiology. 
 
The updated 2016 ESC heart failure guidelines were intended to simplify 
diagnosing patients and a new category, Heart Failure with mid range Ejection 
Fraction  (HFmrEF) was introduced. However, our research has shown that there 
is a small number of patients that have heart failure symptoms, raised natriuretic 
peptides and impaired left ventricular ejection fraction (LVEF: 40-49%) but 
without structural heart disease or diastolic dysfunction. This means that these 
patients have heart failure but do not fit into the new guidelines. From our 
research, we believe these patients may have a better outcome, with none of 
these patients experiencing deteriorating LVEF during follow up. This distinction 
is important; as it is likely that one size does not fit all for HFmrEF patients.  
 
I can confirm that all authors have participated in the work and have reviewed 
and agree with the content of the article. None of the article contents are under 
consideration for publication in any other journal or have been published in any 
journal. No portion of the text has been copied from other material in the 
literature.  
 
Yours faithfully,  
 
 
Dr Jessica Webb 
Cover Letter
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    Department of Biomechanical Engineering 
Rayne Institute, Lambeth Wing, 3rd floor 
King’s College London, London SE1 7EH 
 
29th August 2018 
 
Dear Professor William Roberts, 
 
 
What proportion of patients with Heart Failure and LVEF 40-49% fulfil the 
criteria for Heart Failure with mid range Ejection Fraction? 
 
We are pleased to submit our revised manuscript for publication in AJC. We 
thank you for you thoughtful comments and have amended our manuscript in 
accordance with their recommendations.  
 
I confirm that all authors have contributed significantly to this work, that this work 
is not under consideration elsewhere and that there are no conflicts of interest. 
 
Yours faithfully,  
 
 
Dr Jessica Webb 
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Response to the Reviewers comments 
 
 Incorporate my editorial changes into your revision (See copy marked 
"WCR" to be found under 'Action Links' 'Manage Review Attachments.'). 
This has been done.  
 
 I altered your title by spelling out "LVEF" (see above); additionally, the first 
letter of each major word in the title should be in capital letters (see 
above). This has been changed 
 
 All paragraphs should be fully indented. This has been changed 
 
 Your references need major attention (see copy marked 'WCR"): they 
should be double spaced; the names of all authors are required in every 
reference (do not use 'et al'); the names of the referenced journals should 
be in italics; proper abbreviations should be used for the names of all 
referenced journals; periods should not be placed after the name of any 
referenced journal; full inclusive pages are needed in every reference 
(140-149 not 140-9). Your figure should be in a separate file attached after 
the manuscript. Thank you. This has been modified 
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The ESC updated guidelines introducing Heart Failure with mid range Ejection 
Fraction (HFmrEF) were not validated prior to publication 1. The relative importance 
of stuctural heart disease or diastolic dysfunction in diagnosing HFmrEF is not 
known. Moreover, the exact prevalence remains unclear largely because different 
LVEF have been used to define these ‘grey area’ patients 2-4.  
The aim of this study was to establish the clinical impact of these guidelines. 
All consecutive patients admitted to hospital with HF were recruited over a 12 month 
period (follow up: 26.8 months, range 22.1-34.0). A diagnosis of new HF was made 
by an expert physician and patients were categorised with structural heart disease 
and/or diastolic dysfunction, and so whether they reached the ESC criteria for 
HFmrEF. Patients were ≥18 years of age and were included if in New York Heart 
Association (NYHA) functional class II-IV.  
In total, 677 patients had a new diagnosis of HF, of which 142 patients (21%) 
were identified with LVEF 40-49%; but only 88.7% satisfied the ESC criteria for 
HFmrEF with evidence of diastolic dysfunction and/or structural heart disease. 66 
patients had left atrial enlargement, 64 patients had left ventricular hypertrophy, 81 
patients had e’ <9cm/s and 51 patients had E/e’ ≥ 13. In total, 16 patients (11.3%) 
were admitted with heart failure, raised NTproBNP and LVEF 40-49% but with no 
evidence of diastolic dysfunction and/or structural heart disease, and so were not 
categorised as HFmrEF, Figure 1.  
These 16 patients were more likely to be male (p 0.02), anaemic (p 0.03), iron 
deficient (p 0.04) and have more comorbidities (p 0.01) than the patients who fulfilled 
the HFmrEF criteria. Follow up was 100% complete. There was no difference in all 
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cause death (0.15) or HF hospitalisation (p 0.33) between the true and the HFmrEF 
patients without structural heart disease or diastolic dysfunction. Despite comparable 
medical therapies, fewer of the patients without true HFmrEF transitioned to HFrEF, 
compared to those ‘true’ HFmrEF patients (p 0.05).  
The diagnostic criteria for HFmrEF have never been validated in clinical 
studies and our data suggests that implementing this classification ignores a subset 
of patients. This is the first publication on HFmrEF that has separated out patients 
with HF and LVEF 40-49% into true ‘HFmrEF’ patients and HF LVEF 40-49% without 
structural heart disease or diastolic dysfunction. This distinction is important as it is 
likely that one size does not fit all for HFmrEF patients, and that there is a cohort of 
‘ignored’ patients without structural heart disease or diastolic dysfunction that can be 
easily defined.  
The benefit of this updated ESC classification must be called into question. 
These patients are not a new population 5 but rather one that have been poorly 
described previously and current efforts have not improved the situation. Current 
estimates worldwide are that there are 26 million patients with HF, more than the 
entire population of Australia 6. Extending this worldwide analogy, there are the 
same number of patients with HFmrEF as the entire population of Singapore. With 
such large numbers, more work is needed to understand this population and the 
accuracy of the diagnostic criteria.   
Dr Jessica Webb, PhD, Jane Draper, Gerald Carr-White PhD; Guys and St Thomas’ 
NHS Foundation Trust, London, United Kingdom 
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Figure 1: All HF patients with LVEF 40-49% and either diastolic dysfunction or 
evidence of structural heart disease 
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